Articles From: Darling International Inc. Announces Public Offering Of Common Stock to Data From Intercept's Pivotal Phase 3 POISE Trial of Its FXR Agonist Obeticholic Acid to Treat Primary Biliary Cirrhosis and Other Key Obeticholic Acid Data to be Presented at EASL 2014


2013/12/9
IRVING, Texas , Dec.
Sign-up for Darling International Inc. Announces Public Offering Of Common Stock investment picks
2014/2/26
IRVING, Texas , Feb.
Sign-up for Darling International Inc. Announces Results For Fourth Quarter And Fiscal 2013 investment picks
2013/8/8
IRVING, Texas , Aug.
Sign-up for Darling International Inc. Announces Second Quarter 2013 Results investment picks
IRVING, Texas , Nov.
Sign-up for Darling International Inc. Announces Third Quarter 2013 Results investment picks
IRVING, Texas , Aug.
Sign-up for Darling International Inc. Completes Terra Renewal Services, Inc. Acquisition investment picks
2013/10/28
IRVING, Texas , Oct.
Sign-up for Darling International Inc. Completes the Rothsay Rendering Business Acquisition investment picks
IRVING, Texas , Jan.
Sign-up for Darling International Inc. Completes The VION Ingredients Acquisition investment picks
IRVING, Texas , Aug.
Sign-up for Darling International Inc. To Acquire Terra Renewal Services, Inc. investment picks
2013/8/23
IRVING, Texas , Aug.
Sign-up for Darling International Inc. To Acquire The Rothsay Rendering Business From Maple Leaf Foods Inc. investment picks
2013/10/7
Darling International Inc. To Acquire Vion Ingredients From Vion Holding N.V. Canada NewsWire IRVING, Texas , Oct.
Sign-up for Darling International Inc. To Acquire Vion Ingredients From Vion Holding N.V. investment picks
2013/10/7
IRVING, Texas , Oct.
Sign-up for Darling International Inc. To Acquire Vion Ingredients From Vion Holding N.V. investment picks
2014/2/6
IRVING, Texas , Feb.
Sign-up for Darling International Inc. To Present At The J.P. Morgan Global High Yield & Leveraged Finance Conference investment picks
IRVING, Texas , Aug.
Sign-up for Darling International Inc. Updates On Diamond Green Diesel investment picks
Darling International Inc. (DAR) agreed to purchase Vion Holding N.V.'s Vion Ingredients business for about EUR1.6 billion ($2.17 billion) in cash, giving the food-industry services company new animal by-product lines and greater exposure to Europe.
Sign-up for Darling International to Buy Vion Ingredients for $2.17 Billion investment picks
2013/7/31
IRVING, Texas , July 31, 2013 /PRNewswire/ -- Darling International Inc. (NYSE: DAR) announced today that management will participate in the Jefferies 2013 Global Industrials Conference, being held at The Grand Hyatt Hotel in New York City .
Sign-up for Darling International to Present at Jefferies 2013 Global Industrials Conference investment picks
Top 10 CNN "Hero of the Year" Danielle Gletow Accepts Toyota Highlander for Nonprofit One Simple Wish TORRANCE, Calif.
Sign-up for Darryl "D.M.C." McDaniels Helps Deliver First Vehicle As 100 Cars For Good Concludes Third Powerful Year investment picks
2014/3/19
VISIUS iMRI and iCT expected to expand surgical vision and precision and further research MINNEAPOLIS , March 19, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS) (TSX: IM) ("IMRIS" or the "Company") today announced that neurosurgeons at Dartmouth-Hitchcock Medical Center (DHMC) in Lebanon, NH , have completed several cases to inaugurate use of intraoperative MRI (iMRI) within the VISIUS ® Surgical Theatre inside the hospital's Center for Surgical Innovation (CSI). The CSI has the only operating suite in the world with both VISIUS iMRI and intraoperative CT (iCT) modalities able to serve multiple operating rooms (ORs) without moving the patient.
Sign-up for Dartmouth-Hitchcock Medical Center inaugurates unique intraoperative MRI and CT suite with initial brain tumor procedures in Center for Surgical Innovation investment picks
2014/3/19
Dartmouth-Hitchcock Medical Center inaugurates unique intraoperative MRI and CT suite with initial brain tumor procedures in Center for Surgical Innovation Canada NewsWire VISIUS iMRI and iCT expected to expand surgical vision and precision and further research MINNEAPOLIS , March 19, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS) (TSX: IM) ("IMRIS" or the "Company") today announced that neurosurgeons at Dartmouth-Hitchcock Medical Center (DHMC) in Lebanon, NH , have completed several cases to inaugurate use of intraoperative MRI (iMRI) within the VISIUS ® Surgical Theatre inside the hospital's Center for Surgical Innovation (CSI). The CSI has the only operating suite in the world with both VISIUS iMRI and intraoperative CT (iCT) modalities able to serve multiple operating rooms (ORs) without moving the patient.
Sign-up for Dartmouth-Hitchcock Medical Center inaugurates unique intraoperative MRI and CT suite with initial brain tumor procedures in Center for Surgical Innovation investment picks
2014/4/1
From celebrities tackling home remodels to regular folks renovating their homes, DIY Network will premiere seven new series that focus on the realities of home improvement.
Sign-up for Daryl Hall and William Shatner to Join DIY Network’s Celebrity Roster in 2014 investment picks
One in 10 Minnesotans will struggle to find enough food this week, and these people currently combine to miss a total of 100 million meals every year.
Sign-up for Dash for Hunger to Kick Off “Give A Little, Feed A Lot” Hunger Awareness Campaign at Cub Foods investment picks
--Dassault looks to capitalize on demand for jets with longer range, big living space --Falcon 5X has been secretly in development since 2009 --Aircraft is expected to make first flight in 2015 By Jon Ostrower LAS VEGAS--Dassault Aviation SA unveiled plans Monday to develop a new business jet, firing back at competitors in the U.S. and Canada in the race to offer continent-hopping corporations and the ultra-wealthy more spacious cabins.
Sign-up for Dassault Announces New Falcon 5X Business Jet investment picks
2014/3/26
By William Horobin PARIS--France's Dassault Syst��mes (DSY.FR) on Wednesday extended its public tender offer for all shares of U.S.-based Accelrys Inc. (ACCL) to April 8 pending an investigation by U.S. authorities relating to national security concerns.
Sign-up for Dassault Systèmes Extends Offer for Accelrys investment picks
2014/4/9
The French software company said the Committee on Foreign Investment in the United States is required to complete its investigation of the acquisition until May 8 but could complete it earlier than that.
Sign-up for Dassault Systemes Extends Offer for Accelrys investment picks
PARIS--France's largest software company, Dassault Systemes (DSY.FR), said Thursday that it will make an all-cash tender offer for all of the outstanding shares of U.S.-based Accelrys Inc. (ACCL), a company that provides software for chemistry, biology and materials science research.
Sign-up for Dassault Systemes to Make $750 Million Tender Offer for Accelrys investment picks
2014/1/12
By Victor Reklaitis, MarketWatch NEW YORK (MarketWatch) -- It's not just Target Corp.
Sign-up for Data breach extends beyond Target, Neiman investment picks
2013/8/7
http://media.marketwire.com/attachments/200805/436326_200pixlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1040829&ProfileId=051205&sourceType=1 FRIENDSWOOD, TX --
Sign-up for Data Call Technologies Launches the New DLMedia Product investment picks
Bio-Path Holdings, Inc. (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that there will be a poster presentation by Dr.
Sign-up for Data from Bio-Path Holdings Phase I Clinical Trial in Hematological Cancers to be Presented at American Society of Hematology Annual Meeting investment picks
2014/4/4
NEW YORK, April 4, 2014 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) , a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases, today announced presentations of key data at the International Liver Congress 2014, the 49 th Annual Meeting of the European Association for the Study of the Liver (EASL), being held in London, UK, at the ExCel Centre from April 9-13, 2014.
Sign-up for Data From Intercept's Pivotal Phase 3 POISE Trial of Its FXR Agonist Obeticholic Acid to Treat Primary Biliary Cirrhosis and Other Key Obeticholic Acid Data to be Presented at EASL 2014 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Darling International Inc. Announces Public Offering Of Common Stock to Data From Intercept's Pivotal Phase 3 POISE Trial of Its FXR Agonist Obeticholic Acid to Treat Primary Biliary Cirrhosis and Other Key Obeticholic Acid Data to be Presented at EASL 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity